FDA approves new treatment for advanced prostate cancer
WEBJul 12, 2023 · In June, the FDA approved a new treatment for the most advanced type of prostate cancer. Patients who have this condition, which is called metastatic castration-resistant prostate cancer (mCRPC), have few therapeutic options, so the approval helps to fill an urgent need.
FDA Approves Promising Therapy for Advanced Prostate Cancer: …
WEBMar 23, 2022 · Prostate cancer treatment took a major step forward today as the U.S. Food and Drug Administration approved a new therapy that zeros in on cancer cells to destroy them. The treatment, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface called PSMA (prostate-specific ...
Xtandi Approved for High-Risk Prostate Cancer - NCI
WEBJan 5, 2024 · Enzalutamide (Xtandi) can now be used alone or combined with leuprolide to treat some people with prostate cancer who have had a biochemical recurrence.
A Promising New Therapy for Advanced Prostate Cancer
WEBJun 3, 2021 · Prostate cancer treatment stands on the brink of a major advance with the development of a new treatment that zeros in on cancer cells to destroy them. The therapy, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface.
Prostate Cancer News - ScienceDaily
WEBAug 22, 2024 · Learn the symptoms of prostate cancer. Read current medical research on new treatment options, vaccines, surgery and prevention.
New radiation therapy for prostate cancer reduces deaths ... - NBC News
WEBJun 3, 2021 · The trial was investigating a new, potentially groundbreaking type of treatment for prostate cancer, a therapy that specifically targets a protein on the cancer cells.
FDA Approves Relugolix for Advanced Prostate Cancer
WEBJan 26, 2021 · A new drug approved by the Food and Drug Administration (FDA) is expected to immediately affect the treatment of some men with prostate cancer. In a large clinical trial, the drug, relugolix (Orgovyx), was shown to be more effective at reducing testosterone levels in men with advanced prostate …
A new treatment for advanced prostate cancer improves survival …
WEBJul 12, 2021 · One of these new therapies is now generating promising data for men with the most aggressive prostate cancer. Radiation therapy is getting more precise, making it easier to kill tumors while sparing their surrounding tissues.
Darolutamide Extends Survival in Metastatic Prostate Cancer
WEBMar 25, 2022 · Adding darolutamide (Nubeqa) to ADT and docetaxel improves survival in hormone-sensitive metastatic prostate cancer, results from the ARASENS trial show.
Promising new options for treating aggressive prostate cancer
WEBOct 18, 2023 · Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer -- both of which helped patients live longer without their disease...